Absci Corporation’s ABSI share price has surged by 17.57%, which has investors questioning if this is right time to sell.

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...

On Monday, Absci Corp (ABSI) stock saw a decline, ending the day at $3.81 which represents a decrease of $-0.19 or -4.75% from the prior close of $4. The stock opened at $3.88 and touched a low of ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

Absci Corp (ABSI) stock saw a modest uptick, ending the day at $2.9 which represents a slight increase of $0.10 or 3.57% from the prior close of $2.8. The stock opened at $2.86 and touched a low of $2 ...

Approximately 16.8% of the shares of the stock are short sold. A number of hedge funds have recently modified their holdings of ABSI. Barclays PLC boosted its holdings in Absci by 379.6% during ...

Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Absci's stock. This examination reveals shifts in analysts' expectations over time.

Absci recently received a $20 million PIPE investment ... I've previously covered ABSI, and since then, the stock has been quite volatile. It's now roughly 37.3% lower than my last article back ...

Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company ...

Absci Corp is the Artificial intelligence powered ... Analysts typically rate each stock once per quarter. Some analysts publish their predictions for metrics such as growth estimates, earnings ...

Absci aims to transform biologics development ... "ACTIVE INVESTORS' SECRET WEAPON" Supercharge Your Stock Market Game with the #1 "news & everything else" trading tool: Benzinga Pro - Click ...